基本信息
文件名称:TLK1-IN-1-生命科学试剂-MCE.pdf
文件大小:460.19 KB
总页数:1 页
更新时间:2025-05-21
总字数:约1.83千字
文档摘要
Hotline:400-820-3792
Inhibitors?ScreeningLibraries?Proteins
www.MedChemE
TLK1-IN-1
Cat.No.:HY-173186
分?式:C??H??BrClN?O?
分?量:544.83
作?靶点:Ser/ThrKinase
作?通路:MetabolicEnzyme/Protease
储存?式:Pleasestoretheproductundertherecommendedconditionsin
theCertificateofAnalysis.
BIOLOGICALACTIVITY
?物活性TLK1-IN-1(Compound5n)是?种TLK1抑制剂,对TLK1B的IC50为7.2μM,对LNCaP细胞的GI50为2.7
μM。TLK1-IN-1诱导癌细胞DNA损伤和凋亡(Apoptosis),可?于前列腺癌领域的研究[1]。
REFERENCES
[1].JohnsonD,etal.Characterizationofnewnon-ATPdependentinhibitorsofTLK1aspotentialmoleculesfortreatingprostatecancer.
BioorgChem.2025May;158:108317.
McePdfHeight
Caution:Producthasnotbeenfullyvalidatedformedicalapplications.
Forresearchuseonly.
Tel:400-820-3792;021Fax:021E-mail:tech@MedChemE
1/1MasterofBioactiveMolecules—您?边的抑制剂?师